These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
Pubmed for Handhelds
PUBMED FOR HANDHELDS
Journal Abstract Search
741 related items for PubMed ID: 18376503
1. [Clinical impact of antibiotic resistance in respiratory tract infections]. Klugman K. Med Mal Infect; 2007 Nov; 37 Spec No 1():6-10. PubMed ID: 18376503 [No Abstract] [Full Text] [Related]
3. [Use of antibiotics in the treatment of community-acquired infections of the lower respiratory tract in the elderly]. Sanguinetti CM. Int J Clin Pract Suppl; 2000 Jan; (109):8-10. PubMed ID: 10765555 [No Abstract] [Full Text] [Related]
7. [Management of community-acquired lower respiratory infections. Management in the hospital]. Chidiac C. Rev Mal Respir; 1999 Jan; 16 Suppl 3():S11-2. PubMed ID: 10088221 [No Abstract] [Full Text] [Related]
8. Is it bacterial or viral? Criteria for distinguishing bacterial and viral infections. Benninger M, Segreti J. J Fam Pract; 2008 Feb; 57(2 Suppl Managing):S5-11. PubMed ID: 18662527 [No Abstract] [Full Text] [Related]
9. Appropriate antibiotic therapy for community-acquired respiratory tract infections. Gerbino PP, Brixner D, Sbarbaro J, Nicolau D. Manag Care Interface; 2005 Dec; 18(12):41-8. PubMed ID: 16405224 [Abstract] [Full Text] [Related]
10. [Epidemiology, diagnosis, antimicrobial therapy and management of community-acquired pneumonia and lower respiratory tract infections in adults. Guidelines of the Paul-Ehrlich-Society for Chemotherapy, the German Respiratory Society, the German Society for Infectiology and the Competence Network CAPNETZ Germany]. Höffken G, Lorenz J, Kern W, Welte T, Bauer T, Dalhoff K, Dietrich E, Ewig S, Gastmeier P, Grabein B, Halle E, Kolditz M, Marre R, Sitter H, Paul-Ehrlich-Gesellschaft für Chemotherapie, Deutschen Gesellschaft für Pneumologie und Beatmungsmedizin, Deutschen Gesellschaft für Infektiologie und vom Kompetenznetzwerk CAPNETZ. Pneumologie; 2009 Oct; 63(10):e1-68. PubMed ID: 19821215 [No Abstract] [Full Text] [Related]
11. Novel agents for the treatment of outpatient respiratory tract infections. Introduction. Pell DM. Postgrad Med; 2002 Sep; 112(3 Suppl):5-6. PubMed ID: 19667592 [No Abstract] [Full Text] [Related]
13. Respiratory infections in the community. A concise update. Ferguson J. Aust Fam Physician; 1998 Oct; 27(10):883-7. PubMed ID: 9798285 [Abstract] [Full Text] [Related]
14. Primary care challenges in the management of respiratory tract infections. JAAPA; 2006 Sep; Suppl():4-14; quiz 15-6. PubMed ID: 17001773 [Abstract] [Full Text] [Related]
15. The development of pharmacokinetically enhanced amoxicillin/clavulanate for the management of respiratory tract infections in adults. File TM. Int J Antimicrob Agents; 2007 Dec; 30 Suppl 2():S131-4. PubMed ID: 18029151 [Abstract] [Full Text] [Related]
16. [Antibiotic therapy of bacterial respiratory tract infections]. Schauer J. Z Gesamte Inn Med; 1992 Sep; 47(9):398-403. PubMed ID: 1441667 [Abstract] [Full Text] [Related]
17. Respiratory tract infections: at-risk patients, who are they? Implications for their management with levofloxacin. Sollet JP. Int J Antimicrob Agents; 2006 Sep; 28 Suppl 2():S113-4. PubMed ID: 16904296 [Abstract] [Full Text] [Related]
18. Antimicrobial drugs in the treatment of respiratory infections. Sen P. J Indian Med Assoc; 1979 Jul 01; 73(1):18-20. PubMed ID: 536598 [No Abstract] [Full Text] [Related]
19. [Management of lower respiratory tract infections in immunocompetent adults (community-acquired pneumonia and acute exacerbation of chronic obstructive pulmonary disease): The challenge of a new consensus conference]. Chidiac C. Med Mal Infect; 2006 Jul 01; 36(11-12):535-7. PubMed ID: 17137740 [No Abstract] [Full Text] [Related]
20. Newer fluoroquinolones and the management of respiratory tract infections. Karchmer AW. Clin Infect Dis; 2000 Aug 01; 31 Suppl 2():S15. PubMed ID: 10984322 [No Abstract] [Full Text] [Related] Page: [Next] [New Search]